Form 4 for ISRG Intuitive Surgical
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-08 · accession 0001035267-24-000122 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-11 | 2024-03-08+ | ISRG | DeSantis Robert | EVP, Chief Strategy, Corp Op | M - OptEx | $296.43 | +15.1K | 12.5K | New | +$4.46M |
| DM | 2024-03-11 | 2024-03-08+ | ISRG | DeSantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $393.74 | -20.6K | 11.1K | -65% | -$8.12M |
| DM | 2024-03-11 | 2024-03-08+ | ISRG | DeSantis Robert | EVP, Chief Strategy, Corp Op | M - OptEx | $0.00 | -15.1K | 4,190 | -78% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-08 | M | A | 1,436 | $229.39 | 12,511 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-08 | S | D | 1,437 | $393.80 | 11,075 | D | — | — | (F6) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.00 as follows: 317 shares sold at $391.89 to $392.02; 1,020 shares sold at $393.72 to $394.61; and 100 shares sold at $395.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2024-03-08 | M | A | 940 | $208.90 | 12,015 | D | — | — | |
| 4 | Common | Common Stock | 2024-03-08 | S | D | 940 | $393.82 | 11,075 | D | — | — | (F7) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.32 as follows: 458 shares sold at $391.89 to $392.02; 780 shares sold at $393.22 to $394.14; 1,134 shares sold at $394.27 to $394.82; and 4 shares sold at $395.32. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2024-03-08 | S | D | 2,819 | $393.79 | 8,256 | D | — | — | (F8) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 525 shares sold at $391.89 to $392.02; 1,876 shares sold at $393.55 to $394.53; and 418 shares sold at $394.60 to $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2024-03-08 | S | D | 2,749 | $393.83 | 5,507 | D | — | — | (F9) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 515 shares sold at $391.89 to $392.02; 2,034 shares sold at $393.65 to $394.61; and 200 shares sold at $394.60 to $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 7 | Common | Common Stock | 2024-03-11 | M | A | 90 | $179.70 | 5,597 | D | — | — | |
| 8 | Common | Common Stock | 2024-03-11 | S | D | 90 | $390.16 | 5,507 | D | — | — | |
| 9 | Common | Common Stock | 2024-03-11 | M | A | 119 | $304.67 | 5,626 | D | — | — | |
| 10 | Common | Common Stock | 2024-03-11 | S | D | 119 | $390.16 | 5,507 | D | — | — | |
| 11 | Common | Common Stock | 2024-03-11 | M | A | 120 | $229.39 | 5,627 | D | — | — | |
| 12 | Common | Common Stock | 2024-03-11 | S | D | 120 | $390.16 | 5,507 | D | — | — | |
| 13 | Common | Common Stock | 2024-03-08 | M | A | 1,504 | $290.33 | 12,579 | D | — | — | |
| 14 | Common | Common Stock | 2024-03-08 | S | D | 1,504 | $393.81 | 11,075 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 327 shares sold at $391.89 to $392.02; 1,077 shares sold at $393.73 to $394.61; and 100 shares sold at $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 15 | Common | Common Stock | 2024-03-08 | M | A | 7,149 | $347.42 | 18,224 | D | — | — | |
| 16 | Common | Common Stock | 2024-03-08 | S | D | 7,149 | $393.78 | 11,075 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.05 as follows: 1,277 shares sold at $391.89 to $392.02; 157 shares sold at $392.50 to $392.52; 4,145 shares sold at $393.53 to $394.53; and 1,570 shares sold at $394.56 to $395.05. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 17 | Common | Common Stock | 2024-03-08 | M | A | 993 | $245.60 | 12,068 | D | — | — | |
| 18 | Common | Common Stock | 2024-03-08 | S | D | 993 | $393.80 | 11,075 | D | — | — | (F4) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.00 as follows: 318 shares sold at $391.89 to $392.02; 1,028 shares sold at $393.72 to $394.61; and 100 shares sold at $395.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 19 | Common | Common Stock | 2024-03-08 | M | A | 453 | $242.34 | 11,528 | D | — | — | |
| 20 | Common | Common Stock | 2024-03-08 | S | D | 453 | $393.80 | 11,075 | D | — | — | (F4) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.00 as follows: 318 shares sold at $391.89 to $392.02; 1,028 shares sold at $393.72 to $394.61; and 100 shares sold at $395.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 21 | Common | Common Stock | 2024-03-08 | M | A | 363 | $179.70 | 11,438 | D | — | — | |
| 22 | Common | Common Stock | 2024-03-08 | S | D | 363 | $393.80 | 11,075 | D | — | — | (F5) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.80 as follows: 223 shares sold at $391.89 to $392.02 and 593 shares sold at $394.00 to $394.80. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 23 | Common | Common Stock | 2024-03-08 | M | A | 453 | $177.99 | 11,528 | D | — | — | |
| 24 | Common | Common Stock | 2024-03-08 | S | D | 453 | $393.80 | 11,075 | D | — | — | (F5) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.80 as follows: 223 shares sold at $391.89 to $392.02 and 593 shares sold at $394.00 to $394.80. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 25 | Common | Common Stock | 2024-03-08 | M | A | 1,437 | $304.67 | 12,512 | D | — | — | |
| 26 | Common | Common Stock | 2024-03-08 | S | D | 1,436 | $393.82 | 11,075 | D | — | — | (F7) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.32 as follows: 458 shares sold at $391.89 to $392.02; 780 shares sold at $393.22 to $394.14; 1,134 shares sold at $394.27 to $394.82; and 4 shares sold at $395.32. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 27 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-11 | M | D | 120 | $0.00 | 4,190 | D | $229.39 · — to 2030-02-27 | 120 Common Stock | (F13) 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. |
| 28 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-08 | M | D | 453 | $0.00 | 0 | D | $177.99 · — to 2030-02-28 | 453 Common Stock | (F10) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 29 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-08 | M | D | 363 | $0.00 | 270 | D | $179.70 · — to 2030-05-11 | 363 Common Stock | (F11) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time. |
| 30 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-11 | M | D | 90 | $0.00 | 180 | D | $179.70 · — to 2030-05-11 | 90 Common Stock | (F11) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time. |
| 31 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-08 | M | D | 940 | $0.00 | 4,511 | D | $208.90 · — to 2029-08-28 | 940 Common Stock | (F12) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 32 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-08 | M | D | 1,436 | $0.00 | 4,310 | D | $229.39 · — to 2030-02-27 | 1,436 Common Stock | (F13) 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. |
| 33 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-08 | M | D | 7,149 | $0.00 | 2,382 | D | $347.42 · — to 2031-08-26 | 7,149 Common Stock | (F12) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 34 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-08 | M | D | 453 | $0.00 | 0 | D | $242.34 · — to 2030-08-28 | 453 Common Stock | (F12) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 35 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-08 | M | D | 993 | $0.00 | 2,382 | D | $245.60 · — to 2031-02-26 | 993 Common Stock | (F10) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 36 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-08 | M | D | 1,504 | $0.00 | 4,512 | D | $290.33 · — to 2029-02-28 | 1,504 Common Stock | (F10) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 37 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-08 | M | D | 1,437 | $0.00 | 4,309 | D | $304.67 · — to 2030-08-09 | 1,437 Common Stock | (F14) 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. |
| 38 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-11 | M | D | 119 | $0.00 | 4,190 | D | $304.67 · — to 2030-08-09 | 119 Common Stock | (F14) 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. |